Concepts (48)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arachidonic Acid | 1 | 2025 | 68 | 0.910 |
Why?
|
| Neutrophils | 2 | 2025 | 359 | 0.830 |
Why?
|
| Triple Negative Breast Neoplasms | 2 | 2025 | 273 | 0.770 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2025 | 816 | 0.650 |
Why?
|
| Bone Neoplasms | 3 | 2025 | 445 | 0.430 |
Why?
|
| Tumor Microenvironment | 5 | 2025 | 688 | 0.410 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2025 | 133 | 0.210 |
Why?
|
| Myeloid Cells | 1 | 2024 | 118 | 0.210 |
Why?
|
| Immune Tolerance | 1 | 2024 | 153 | 0.210 |
Why?
|
| Ecosystem | 1 | 2023 | 105 | 0.190 |
Why?
|
| Osteogenesis | 1 | 2023 | 163 | 0.180 |
Why?
|
| Single-Cell Analysis | 1 | 2025 | 353 | 0.180 |
Why?
|
| B-Lymphocytes | 1 | 2024 | 542 | 0.180 |
Why?
|
| Neoplasms | 2 | 2025 | 2944 | 0.150 |
Why?
|
| Neoplasm Metastasis | 1 | 2021 | 725 | 0.140 |
Why?
|
| Cell Line, Tumor | 1 | 2025 | 3693 | 0.130 |
Why?
|
| Myelopoiesis | 2 | 2024 | 12 | 0.110 |
Why?
|
| Mice | 3 | 2025 | 18559 | 0.100 |
Why?
|
| Prostatic Neoplasms | 1 | 2021 | 1577 | 0.090 |
Why?
|
| Animals | 3 | 2025 | 34947 | 0.070 |
Why?
|
| Breast Neoplasms | 1 | 2021 | 2681 | 0.070 |
Why?
|
| Osteoclasts | 1 | 2025 | 72 | 0.060 |
Why?
|
| Humans | 6 | 2025 | 132202 | 0.050 |
Why?
|
| Cell Communication | 1 | 2024 | 187 | 0.050 |
Why?
|
| Matrix Metalloproteinase 13 | 1 | 2023 | 11 | 0.050 |
Why?
|
| High-Temperature Requirement A Serine Peptidase 1 | 1 | 2023 | 5 | 0.050 |
Why?
|
| Female | 3 | 2025 | 70742 | 0.050 |
Why?
|
| Bone Remodeling | 1 | 2023 | 56 | 0.050 |
Why?
|
| Cadherins | 1 | 2023 | 180 | 0.050 |
Why?
|
| Macrophages | 1 | 2025 | 692 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2021 | 316 | 0.040 |
Why?
|
| Mice, SCID | 1 | 2021 | 604 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2021 | 757 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 1 | 2021 | 1047 | 0.040 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2023 | 554 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2021 | 998 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2023 | 1303 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2024 | 1757 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2023 | 1975 | 0.030 |
Why?
|
| Disease Progression | 1 | 2021 | 2225 | 0.030 |
Why?
|
| Apoptosis | 1 | 2021 | 1901 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2021 | 1879 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2021 | 2511 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2021 | 2064 | 0.030 |
Why?
|
| Biomarkers, Tumor | 1 | 2021 | 1683 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2021 | 4765 | 0.020 |
Why?
|
| Middle Aged | 1 | 2024 | 28869 | 0.010 |
Why?
|
| Male | 1 | 2021 | 65011 | 0.010 |
Why?
|